Get the Stockscreener App
68.66
0.04%
0.03
After Hours:
68.52
-0.14
-0.20%
Liquidia Corp stock is traded at $68.66, with a volume of 897.24K.
It is up +0.04% in the last 24 hours and down -22.31% over the past month.
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.
See More
Previous Close:
$68.63
Open:
$67.91
24h Volume:
897.24K
Relative Volume:
0.49
Market Cap:
$6.15B
Revenue:
$288.07M
Net Income/Loss:
$22.31M
P/E Ratio:
484.89
EPS:
0.1416
Net Cash Flow:
$41.15M
1W Performance:
+1.43%
1M Performance:
-22.31%
6M Performance:
+99.71%
1Y Performance:
+138.07%
1-Day Range:
$67.40
$69.47
1-Week Range:
$66.10
$70.75
52-Week Range:
$21.14
$93.61
Liquidia Corp Stock (LQDA) Company Profile
Name
Liquidia Corp
Sector
Phone
919.328.4400
Address
419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC
Compare LQDA vs TAK, TEVA, HLN, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LQDA
Liquidia Corp
|
68.66 | 6.36B | 288.07M | 22.31M | 41.15M | 0.1416 |
TAK
Takeda Pharmaceutical Co Adr
|
18.45 | 57.90B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.36 | 42.89B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.60 | 43.41B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
75.81 | 31.00B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
487.61 | 22.35B | 3.17B | 1.29B | 1.01B | 27.09 |
Liquidia Corp Stock (LQDA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-20-25 | Initiated | Wells Fargo | Overweight |
| Aug-15-25 | Resumed | Jefferies | Buy |
| May-19-25 | Downgrade | Oppenheimer | Perform → Underperform |
| Dec-20-24 | Initiated | Wells Fargo | Overweight |
| Oct-16-24 | Initiated | Scotiabank | Sector Outperform |
| Aug-19-24 | Upgrade | Raymond James | Outperform → Strong Buy |
| Aug-16-24 | Initiated | Raymond James | Outperform |
| Jun-25-24 | Initiated | Oppenheimer | Perform |
| Jan-05-24 | Reiterated | Needham | Buy |
| Sep-19-22 | Resumed | Wedbush | Underperform |
| Sep-01-22 | Downgrade | Wedbush | Neutral → Underperform |
| Jul-22-22 | Initiated | Ladenburg Thalmann | Buy |
| May-31-22 | Initiated | BTIG Research | Buy |
| May-26-22 | Initiated | BofA Securities | Buy |
| Dec-04-20 | Initiated | H.C. Wainwright | Buy |
| Nov-20-20 | Downgrade | Wedbush | Outperform → Neutral |
| Nov-08-18 | Resumed | Jefferies | Buy |
| Sep-05-18 | Initiated | Wedbush | Outperform |
| Aug-20-18 | Initiated | Jefferies | Buy |
| Aug-20-18 | Initiated | Needham | Buy |
View All
Liquidia Corp Stock (LQDA) Latest News
Liquidia Corp Stock Intrinsic Values - GuruFocus
Liquidia Corp CHRO Sarah Krepp Sells 274 Shares Under Pre-Set 10b5-1 Trading Plan - kalkinemedia.com
Liquidia Corp (NASDAQ: LQDA) Secures FDA Fast Track for YUTREPIA Targeting Raynaud’s Phenomenon in Up to 90% of Systemic Sclerosis Patients - Kalkine Media
How Does Liquidia Corporation's (NASDAQ:LQDA) PRINT Platform Actually Work? - Kalkine Media
Why Is Liquidia Stock Gaining Thursday?Liquidia (NASDAQ:LQDA) - Benzinga
Liquidia Corporation’s (LQDA) Yutrepia Launch Continues to Outpace the Expectations - Yahoo Finance
LQDA Looks 75.0% Undervalued on GF Value™ - GuruFocus
Liquidia’s YUTREPIA Receives FDA Fast Track Designation for Systemic Sclerosis-Associated Raynaud’s Phenomenon - Quiver Quantitative
Liquidia Gets FDA Fast Track for YUTREPIA Raynaud's | LQDA Stock News - Stock Titan
Liquidia Corporation $LQDA Shares Sold by Pale Fire Capital SE - MarketBeat
Liquidia Corporation (NASDAQ:LQDA) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat
Liquidia Corp (LQDA) Shares Surge 4.1% -- What GF Score of 70 Te - GuruFocus
Liquidia to Present Posters at the European Respiratory Society (ERS) 2026 Congress - Yahoo Finance
Liquidia Corporation to Participate in Wells Fargo Annual Healthcare Conference - The Manila Times
Liquidia Corp Stock Operating Data - GuruFocus
Can LQDA's Yutrepia Sustain Growth Amid Fierce PAH Competition? - Yahoo Finance
Q1 2025 Liquidia Corp Earnings Call Transcript - GuruFocus
Liquidia Corp (HAM:LT4) Valuation: Possible Value Trap, Think Twice - GuruFocus
Liquidia Corp (HAM:LT4)Valuation Measures & Financial Statistics - GuruFocus
HAM:LT4 Dividend: Does Liquidia Corp Pay a Dividend? - GuruFocus
Who's Buying or Selling Liquidia Corp (HAM:LT4) Stock Today? - GuruFocus
Liquidia Corp (HAM:LT4) Stock Price & 30 Year Financial Data - GuruFocus
Liquidia Corp (HAM:LT4) Stock HoldersInstitutional & Insider Ownership - GuruFocus
Liquidia Corp (HAM:LT4) Competitors 2026 - GuruFocus
Bank of New York Mellon Corp Makes New Investment in Liquidia Corporation $LQDA - MarketBeat
Liquidia Corp (LQDA) Stock Down 3.1% -- Now Undervalued? GF Scor - GuruFocus
Liquidia Corporation $LQDA Shares Bought by Seven Fleet Capital Management LP - MarketBeat
Liquidia Slips as Post-Earnings Selling Continues - Quiver Quantitative
Liquidia (NASDAQ:LQDA) Director Katherine Rielly-Gauvin Sells 36,789 Shares of Stock - MarketBeat
Insider at Liquidia (NASDAQ: LQDA) plans multimillion-dollar stock sale - Stock Titan
Liquidia (NASDAQ: LQDA) director sells 55K shares in 10b5-1 trades - Stock Titan
Liquidia Corp (LQDA) Shares Fall 5.8% -- What GF Score of 70 Tel - GuruFocus
Liquidia CEO Roger Jeffs Says Demand For Inhaled Lung Disease Drug Is Growing Amid Q2 Revenue Beat - Stocktwits
Liquidia Corp (LQDA) CMO cashes in options, unloads 79K+ shares - Stock Titan
Liquidia (NASDAQ: LQDA) director to sell shares after option exercises - Stock Titan
Liquidia (NASDAQ: LQDA) officer eyes $3.7M Rule 144 stock resale - Stock Titan
Can Yutrepia's Strong Growth Drive Liquidia's PAH Expansion? - Zacks Investment Research
Renaissance Technologies LLC Sells 198,753 Shares of Liquidia Corporation $LQDA - MarketBeat
A Look at Liquidia Corp (LQDA) After 4.3% Gain -- GF Value $267. - GuruFocus
Liquidia (NASDAQ: LQDA) affiliate plans new stock sale after $710K July trade - Stock Titan
LQDA Stock Down Post Q2 Earnings Release: What Should Investors Do Now? - Yahoo Finance
Greenhaven Road Capital: Short Term Gain Realized from Liquidia (LQDA), Investment to Be Revisited - Yahoo Finance
Liquidia (NASDAQ:LQDA) Rating Lowered to "Hold" at Zacks Research - MarketBeat
Teleconferência de Resultados do 2T26 da Liquidia (LQDA): Vendas do YUTREPIA Crescem 31% - TradingKey
Liquidia Corp (LQDA) sees 6.5% stake reported by investor Paul B. Manning - Stock Titan
HC Wainwright Brokers Lower Earnings Estimates for Liquidia - MarketBeat
Liquidia (LQDA) Q2 2026 Earnings Call: YUTREPIA Sales Rise 31% - TradingKey
Why Liquidia Stock Was Diving This Week - The Globe and Mail
Why Liquidia Stock Was Diving This Week - The Motley Fool
Liquidia (LQDA) Stock May Trade At A Premium On Earnings But A Discount On Broader Checks - Yahoo Finance
Liquidia Corp (LQDA) Shares Fall 8.5% -- What GF Score of 70 Tel - GuruFocus
Liquidia Corp Stock (LQDA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.66%
0.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):